Cargando…
OnabotulinumtoxinA effectiveness on chronic migraine, negative emotional states and sleep quality: a single-center prospective cohort study
BACKGROUND: OnabotulinumtoxinA (OnabotA) is considered effective in in patients with chronic migraine (CM) who failed on traditional therapies. This study was designed to evaluate the effect of OnabotA injection series on migraine outcome, negative emotional states and sleep quality in patients with...
Autores principales: | Aydinlar, Elif Ilgaz, Dikmen, Pinar Yalinay, Kosak, Seda, Kocaman, Ayse Sagduyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5315653/ https://www.ncbi.nlm.nih.gov/pubmed/28213829 http://dx.doi.org/10.1186/s10194-017-0723-4 |
Ejemplares similares
-
The relation of sexual function to migraine-related disability, depression and anxiety in patients with migraine
por: Eraslan, Defne, et al.
Publicado: (2014) -
Association between somatic amplification, anxiety, depression, stress and migraine
por: Yavuz, Burcu Goksan, et al.
Publicado: (2013) -
High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis
por: Affatato, Oreste, et al.
Publicado: (2021) -
Cognitive effects of onabotulinumtoxinA in chronic migraine
por: Ho, Susan, et al.
Publicado: (2020) -
OnabotulinumtoxinA: Still the Present for Chronic Migraine
por: Baraldi, Carlo, et al.
Publicado: (2023)